Disease-Area Clinician — Trial Endpoints & Prescribing

Confidential; United States; Remote; USD 138,000 - 276,000; Part time

Job summary

Zekai is seeking a US-based disease-area clinician for a paid, remote pilot to create and critique rubrics analyzing commercial drugs and drug-development programs. The role requires evaluating clinical trial endpoints and judging potential impact on prescribing, with extension possible as the project scales.

The engagement spans roughly 10–20 hours over a 1–2 week period, entirely remote. Board-certified, actively practising physicians with deep therapeutic-area expertise are encouraged to

Qualifications

• Must hold an MD/DO and be board-certified in a medical specialty.
• Practising physician with current licensure in the United States.
• Deep expertise in a specific disease or therapeutic area.

Responsibilities

• Create and critique rubrics that analyze drugs and development programs.
• Interpret trial endpoints and assess impact on prescribing decisions.
• Evaluate real-world uptake implications across the pilot drugs and programs.
• Apply evaluation framework across the pilot's set of drugs.

Skills

Clinical expertise

Biotech/pharma knowledge

Therapeutic area specialist

Board-certified clinician

Education

MD/DO

Job description

our partner is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a disease-area clinician for a paid pilot, with the potential to continue as the work scales.

Responsibilities

• Create and critique rubrics that analyze commercial drugs and drug-development programs
• Interpret clinical trial endpoints and judge whether results would change prescribing
• Assess what that means for real-world uptake in your therapeutic area
• Apply this across the pilot's set of drugs and programs

Requirements

• US-based disease-area clinician (practising physician, MD/DO)
• Familiarity with biotech/pharma development programs
• Deep expertise in a specific therapeutic area
• Board-certified and actively practising in your specialty

Engagement Details

• Duration: Approximately 10–20 hours over a 1–2 week pilot
• Remote — US-based

Why Participate

• Help improve expert AI evaluation of drugs and drug-development programs
• Recurring engagement for strong contributors

This is a 100% remote contract role. Applicants must be located in: United States.